title: A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.
authors: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN mfrye@mayo.edu Department of Internal Medicine and Nicotine Dependence Center, Mayo Clinic, Rochester, MN Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN and Mental/Behavioral Health, VA Health Care System, Minneapolis, MN Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN Division of Biomedical Statistics and Informatics, Mayo Clinic, Department of Health Sciences Research, Rochester, MN Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
authors: Mark A
authors: MA
authors: Frye
authors: Jon O
authors: JO
authors: Ebbert
authors: Courtney A
authors: CA
authors: Prince
authors: Timothy W
authors: TW
authors: Lineberry
authors: Jennifer R
authors: JR
authors: Geske
authors: Christi A
authors: CA
authors: Patten
mesh_terms: D000328:Adult; D001552:Benzazepines / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000503:physiopathology*; D003863:Depression / Q000503:physiopathology; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D011810:Quinoxalines / Q000627:therapeutic use*; D016540:Smoking Cessation / Q000379:methods*; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline